title: Can the CIMP status be used to stratify the colorectal cancer patients who respond to adjuvant chemotherapy?
authors.forename: Jung Wook
authors.initials: JW
authors.lastname: Huh
mesh_terms: D000964:Antimetabolites, Antineoplastic / Q000494:pharmacology*; D014408:Biomarkers, Tumor / Q000235:genetics*; D017024:Chemotherapy, Adjuvant; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology; D018899:CpG Islands / Q000235:genetics*; D019175:DNA Methylation; D016903:Drug Monitoring / Q000379:methods*; D005472:Fluorouracil / Q000494:pharmacology*; D006801:Humans; D010641:Phenotype; D016019:Survival Analysis
chemical_list: D000964:Antimetabolites, Antineoplastic; D014408:Biomarkers, Tumor; D005472:Fluorouracil